Robert H. Belmaker

18.4k total citations · 2 hit papers
291 papers, 13.0k citations indexed

About

Robert H. Belmaker is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert H. Belmaker has authored 291 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Psychiatry and Mental health, 63 papers in Cellular and Molecular Neuroscience and 50 papers in Molecular Biology. Recurrent topics in Robert H. Belmaker's work include Bipolar Disorder and Treatment (110 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Schizophrenia research and treatment (37 papers). Robert H. Belmaker is often cited by papers focused on Bipolar Disorder and Treatment (110 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Schizophrenia research and treatment (37 papers). Robert H. Belmaker collaborates with scholars based in Israel, United States and Germany. Robert H. Belmaker's co-authors include Galila Agam, Richard P. Ebstein, Yamima Osher, Boris Nemets, Lubov Nemanov, Ziva Stahl, Nimrod Grisaru, Yuly Bersudsky, Michael E. Newman and Abraham Danon and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Robert H. Belmaker

284 papers receiving 12.3k citations

Hit Papers

Major Depressive Disorder 1996 2026 2006 2016 2008 1996 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Robert H. Belmaker 4.5k 3.1k 2.7k 2.1k 1.7k 291 13.0k
Bernard Lerer 4.3k 0.9× 2.9k 0.9× 2.8k 1.0× 1.9k 0.9× 1.5k 0.9× 339 12.6k
William G. Honer 5.1k 1.1× 3.1k 1.0× 2.7k 1.0× 1.4k 0.7× 2.4k 1.4× 406 14.0k
Rolf Adolfsson 3.7k 0.8× 1.9k 0.6× 2.1k 0.8× 1.3k 0.6× 2.0k 1.2× 250 13.9k
Wagner F. Gattaz 6.1k 1.3× 2.1k 0.7× 2.5k 0.9× 1.6k 0.8× 2.3k 1.4× 387 14.5k
Dan Rujescu 2.6k 0.6× 2.2k 0.7× 3.1k 1.1× 1.8k 0.9× 2.0k 1.2× 347 11.4k
Wolfgang Maier 5.3k 1.2× 2.3k 0.7× 2.4k 0.9× 3.2k 1.6× 3.8k 2.2× 468 18.7k
Enrico Smeraldi 7.2k 1.6× 3.5k 1.1× 2.1k 0.8× 2.9k 1.4× 3.6k 2.1× 390 15.9k
Hiroshi Kunugi 2.9k 0.6× 3.3k 1.1× 4.2k 1.5× 1.6k 0.8× 2.2k 1.3× 446 15.7k
Andreas Reif 3.6k 0.8× 2.5k 0.8× 2.3k 0.8× 2.4k 1.2× 3.1k 1.8× 466 12.3k
William E. Bunney 4.7k 1.0× 5.3k 1.7× 4.2k 1.6× 1.8k 0.9× 4.3k 2.5× 264 18.7k

Countries citing papers authored by Robert H. Belmaker

Since Specialization
Citations

This map shows the geographic impact of Robert H. Belmaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Belmaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Belmaker more than expected).

Fields of papers citing papers by Robert H. Belmaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Belmaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Belmaker. The network helps show where Robert H. Belmaker may publish in the future.

Co-authorship network of co-authors of Robert H. Belmaker

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Belmaker. A scholar is included among the top collaborators of Robert H. Belmaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Belmaker. Robert H. Belmaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belmaker, Robert H. & Pesach Lichtenberg. (2023). Psychopharmacology Reconsidered.
2.
Guu, Ta‐Wei, David Mischoulon, Jerome Sarris, et al.. (2020). A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder. Journal of Affective Disorders. 265. 233–238. 15 indexed citations
3.
Guu, Ta‐Wei, David Mischoulon, Jerome Sarris, et al.. (2019). International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychotherapy and Psychosomatics. 88(5). 263–273. 133 indexed citations
4.
Blanaru, M., Alon Reshef, Wolfgang Maier, et al.. (2008). Clinical characteristics of schizophrenia: Israeli Bedouin compared with Palestinian Arabs in Israel and the Palestinian Authority. 3(1). 3–6. 1 indexed citations
5.
Belmaker, Robert H. & Galila Agam. (2008). Major Depressive Disorder. New England Journal of Medicine. 358(1). 55–68. 1531 indexed citations breakdown →
6.
Shaltiel, Galit, Emma Dalton, Robert H. Belmaker, Adrian J. Harwood, & Galila Agam. (2007). Specificity of mood stabilizer action on neuronal growth cones. Bipolar Disorders. 9(3). 281–289. 19 indexed citations
7.
Amar, Shirly, Alon Shamir, Ofer Ovadia, et al.. (2007). Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs. Schizophrenia Research. 94(1-3). 354–358. 37 indexed citations
8.
Nemets, Boris, et al.. (2006). Omega-3 Treatment of Childhood Depression: A Controlled, Double-Blind Pilot Study. American Journal of Psychiatry. 163(6). 1098–1100. 263 indexed citations
9.
Cichon, Sven, J Schumacher, Thomas G. Schulze, et al.. (2001). The NOTCH4 locus and schizophrenia: Analyses in the german and palestinian Arab population. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 105(7). 3 indexed citations
10.
Levine, Joseph, et al.. (2001). Inositol Treatment has no Effect on the Dexamethasone Suppression Test. The World Journal of Biological Psychiatry. 2(4). 190–192. 5 indexed citations
11.
Shaltiel, Galit, Alon Shamir, Lubov Nemanov, et al.. (2001). Inositol Monophosphatase Activity in Brain and Lymphocyte-Derived Ceii Lines of Bipolar Patients. The World Journal of Biological Psychiatry. 2(2). 95–98. 19 indexed citations
12.
George, Mark S. & Robert H. Belmaker. (2000). Transcranial magnetic stimulation in neuropsychiatry. 123 indexed citations
13.
Dossenbach, Martín, Robert H. Belmaker, Avner Elizur, et al.. (2000). The effectiveness of olanzapine in treatment-refractory schizophrenia when patients are nonresponsive to or unable to tolerate clozapine. Clinical Therapeutics. 22(9). 1021–1034. 39 indexed citations
14.
Nemets, Boris, Alexander Mishory, Jay F. Levine, & Robert H. Belmaker. (1999). Inositol addition does not improve depression in SSRI treatment failures. Journal of Neural Transmission. 106(7-8). 795–798. 31 indexed citations
15.
Levine, Jay F., et al.. (1997). Inositol treatment of autism. Journal of Neural Transmission. 104(2-3). 307–310. 29 indexed citations
16.
Bergener, Manfred, et al.. (1993). Psychopharmacotherapy for the elderly : research and clinical implications. Springer eBooks. 1 indexed citations
17.
Avissar, Sofia, et al.. (1988). Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 331(6155). 440–442. 400 indexed citations
18.
Shapira, Baruch, et al.. (1985). Potentiation of Seizure Length and Clinical Response to Electroconvulsive Therapy by Caffeine Pretreatment: A Case Report.. PubMed. 1(1). 58–60. 18 indexed citations
19.
Belmaker, Robert H. & H. M. van Praag. (1980). Mania : an evolving concept. 40 indexed citations
20.
Lamprecht, Friedhelm, Richard Jed Wyatt, Robert H. Belmaker, Dennis L. Murphy, & William Pollin. (1974). Plasma dopamine-beta-hydroxylase in identical twins discordant for schizophrenia. Biochemical Pharmacology. 23. 937–940. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026